Thanks Vasily. Good afternoon everyone. Our fourth quarter 2024 results were solid as we exceeded our expectations, both on revenue and non-GAAP EBITDA. We achieved record revenues of $100.3 million, surpassing our guidance range of $95 million to $97 million. On a year-over-year basis, our fourth quarter revenues grew at 28.5%. Excluding our recent acquisitions, our organic revenues grew by 12.8% on a year-over-year basis. The impact of FX on our fourth quarter revenues was minimal, both on a sequential and year-over-year basis. Our non-GAAP EBITDA of $15.6 million exceeded our guidance range of $13.5 million and $15.5 million. The stronger-than-expected performance, both in revenue and profitability was driven by strength from both our organic business and recent acquisitions. The retail vertical remained the largest, accounting for 32.6% of our fourth quarter revenues. It showed sequential and year-over-year growth of 9.7% and 33.1% respectively. During the quarter, we witnessed growth across a wide range of retail customers that included specialty retail, home improvement space, and department store customers. Our TMT and financial verticals contributed 23.5% and 23.1% of our fourth quarter revenues respectively. In the fourth quarter, our TMT vertical remained relatively flat on a dollar basis compared to the third quarter as we were impacted by the typical year-end slowdown at some of our large customers. The finance vertical showed the strongest performance with sequential and year-over-year growth of 63.8% and 180.1% respectively. Strength in the financial vertical was driven by a combination of increased demand from fintech and insurance customers as well as our recent acquisitions. Here are the details of the revenue mix of other verticals. Our CPG and manufacturing, representing 11.2% of our quarter revenues grew sequentially by 14.8% and 16.4% on a year-over-year basis. Strength in this vertical was driven by both our organic business and recent acquisitions. Our other vertical, which represented 7.2% of our fourth quarter revenues grew slightly on a sequential basis, but declined by 11.3% year-over-year. And finally, healthcare and pharma vertical represented 2.4% of our revenues. We ended the fourth quarter with a total headcount of 4,730, up from 4,298 employees in the third quarter of 2024 and up from 3,920 in the fourth quarter of 2023. The sequential growth in headcount was driven by both our organic business and recent acquisitions. At the end of the fourth quarter of 2024, our total U.S. headcount was 351 or 7.4% of the company's total headcount versus 345 or 8% in the third quarter and 331 or 8.4% in the year ago quarter. Our non-U.S. headcount located in Europe, Americas, and India was 4,379 or 92.6%, up from 3,953 or 92% in the third quarter and 3,589 or 91.6% in the year ago quarter. In the fourth quarter, revenues from our top five and top 10 customers were 35.6% and 55.8% respectively versus 39.8% and 59.2% in the third quarter and 39.7% and 55.3% in the same period a year ago respectively. During the fourth quarter, we had a total of 211 customers, up from 201 in the third quarter of 2024 and down from 218 in the year ago quarter. The increase during the quarter was mainly due to customers coming from the acquisitions. The year-over-year decline in the number of customers was primarily driven by our continued efforts to rationalize our portfolio of nonstrategic customers. Moving to the income statement. Our GAAP gross profit during the quarter was $37 million or 36.9% compared to $32.7 million or 37.4% in the third quarter of 2024 and $28.1 million or 36% in the year ago quarter. On a non-GAAP basis, our gross profit was $37.6 million or 37.5%, up from $33.3 million or 38% in the third quarter of 2024 and up from $28.6 million or 36.6% in the year ago quarter. Our non-GAAP EBITDA during the fourth quarter, which excluded interest income, expense, provision for income taxes, and depreciation and amortization and was further adjusted for the impact of stock-based compensation, restructuring expenses related to geographic reorganization and transaction, and other related costs was $15.6 million or 15.6% of revenues, up from $14.8 million or a 16.9% of revenues in the third quarter of 2024 and $10.7 million or 13.7% in the year ago quarter. The dollar increase on a sequential basis was largely due to higher revenues, partially offset by increase in operating expenses. As a percentage of revenues, the decline in non-GAAP EBITDA margin was primarily driven by a combination of lower gross margin as a percentage and higher levels of OpEx, both from organic business and our recent acquisitions. Our GAAP net income in the fourth quarter was $4.5 million or $0.05 per share based on a diluted share count of 83.8 million shares compared to the third quarter income of $4.3 million or $0.05 per share, based on a diluted share count of 78.8 million and an income of $2.9 million or $0.04 per share based on 78 million diluted shares in the year ago quarter. On a non-GAAP basis, in the fourth quarter 2024, our non-GAAP net income was $10.3 million or $0.12 per share based on 83.8 million diluted shares compared to the third quarter non-GAAP net income of $10.8 million or $0.14 per share based on 78.8 million diluted shares and $7.5 million or $0.10 per share, based on 78 million diluted shares in the year ago quarter. On December 31st, 2024, our cash and cash equivalents totaled $334.7 million, up from $231.3 million in the third quarter 2024. The increase in cash was largely driven by our follow-on offering in November of 2024. Coming to the guidance. For the first quarter of 2025, we expect revenues to be in the range of $98 million to $100 million or growth of roughly 23% to 25% on a year-over-year basis. At the midpoint of $99 million, we expect our first quarter revenue to grow by 24% on a year-over-year basis. We expect our non-GAAP EBITDA in the first quarter to be in the range of $12.9 million to $13.9 million. For Q1 2025, we expect our basic share count to be in the range of 84 million to 85 million and our diluted share count to be in the range of 89 million to 90 million. For the full year 2025 we expect revenues to be in the range of $415 million to $435 million, representing a growth of 18.4% to 24.1% on a year-over-year basis. At the midpoint of $425 million, we expect our 2025 revenues to grow by 21.2% on a year-over-year basis. That concludes my prepared remarks. We are now ready to take question.